These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3291635)

  • 1. Serotonin in nasal secretion.
    Tønnesen P; Hindberg I
    Allergy; 1988 May; 43(4):303-9. PubMed ID: 3291635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nasal allergen challenge on serotonin, substance P and vasoactive intestinal peptide in plasma and nasal secretions.
    Tønnesen P; Hindberg I; Schaffalitzky de Muckadell OB; Mygind N
    Allergy; 1988 May; 43(4):310-7. PubMed ID: 2455456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide levels of nasal secretions in allergic patients and control subjects.
    Asakura K; Enomoto K; Azuma E; Sohma S; Kataura A
    Arch Otorhinolaryngol; 1984; 240(3):249-53. PubMed ID: 6091600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene C4 and histamine in early allergic reaction in the nose.
    Bisgaard H; Robinson C; Rømeling F; Mygind N; Church M; Holgate ST
    Allergy; 1988 Apr; 43(3):219-27. PubMed ID: 3377145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of histamine in nasal lavage fluid: comparison of a glass fiber-based fluorometric method with two radioimmunoassays.
    Andersson M; Nolte H; Olsson M; Skov PS; Pipkorn U
    J Allergy Clin Immunol; 1990 Nov; 86(5):815-20. PubMed ID: 2229845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P and vasoactive intestinal peptide in serotonin-induced nasal secretions in normal subjects.
    Tønnesen P; Schaffalitzky de Muckadell OB
    Allergy; 1987 Feb; 42(2):146-50. PubMed ID: 2438962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients.
    Mosimann BL; White MV; Hohman RJ; Goldrich MS; Kaulbach HC; Kaliner MA
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):95-104. PubMed ID: 7687608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal challenge with serotonin in asymptomatic hay fever patients.
    Tønnesen P; Schaffalitzky de Muckadell OB; Mygind N
    Allergy; 1987 Aug; 42(6):447-50. PubMed ID: 2444128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
    Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser high performance liquid chromatography determination of prostaglandins in nasal lavage fluid in allergic rhinitis.
    Sugimoto M; Sugiyama S; Yanagita N; Ozawa T
    Clin Exp Allergy; 1994 Apr; 24(4):324-9. PubMed ID: 7913656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions.
    Raphael GD; Igarashi Y; White MV; Kaliner MA
    J Allergy Clin Immunol; 1991 Jul; 88(1):33-42. PubMed ID: 1712803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions.
    Greiff L; Pipkorn U; Alkner U; Persson CG
    Clin Exp Allergy; 1990 May; 20(3):253-9. PubMed ID: 2364306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endothelin-1 in nasal lavage fluid of allergic rhinitis patients--new mediator of allergic rhinitis].
    Gawlik R; Jawor B
    Otolaryngol Pol; 2007; 61(4):567-71. PubMed ID: 18260253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil recruitment to nasal nerves after allergen challenge in allergic rhinitis.
    Thornton MA; Akasheh N; Walsh MT; Moloney M; Sheahan PO; Smyth CM; Walsh RM; Morgan RM; Curran DR; Walsh MT; Gleich GJ; Costello RW
    Clin Immunol; 2013 Apr; 147(1):50-57. PubMed ID: 23518598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure.
    Wang D; Clement P; Smitz J; De Waele M; Derde MP
    Int Arch Allergy Immunol; 1995 Mar; 106(3):278-85. PubMed ID: 7888790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine concentrations in nasal secretion and secretory activity in allergic rhinitis.
    Linder A; Strandberg K; Deuschl H
    Allergy; 1987 Feb; 42(2):126-34. PubMed ID: 3592134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine releasability after adenosine challenge in subjects with allergic and non-allergic rhinitis: possible implications for mast cell priming.
    Polosa R; Pagano C; Low JL; Church MK; Crimi N
    Ann Ital Med Int; 1999; 14(2):86-93. PubMed ID: 10399370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thresholds in nasal histamine challenge in patients with allergic rhinitis, patients with hyperreflectory rhinopathy, and healthy volunteers.
    Wuestenberg EG; Hauswald B; Huettenbrink KB
    Am J Rhinol; 2004; 18(6):371-5. PubMed ID: 15706984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine in nasal secretions.
    Eggleston PA; Hendley JO; Gwaltney JM; Eggleston AW; Leavell BS
    Int Arch Allergy Appl Immunol; 1978; 57(3):193-200. PubMed ID: 659012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.